Sequential Down syndrome screening: The importance of first and second trimester test correlations when calculating risk

Journal of Genetic Counseling

Volumn 14, Issue 6, 2005, Pages 409-413

  Benn, Peter ^a   Donnenfeld, Alan E ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Genzyme Genetics   (United States)

Author keywords

Down syndrome; First trimester screening; Second trimester screening; Sequential screening

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GENETIC RISK; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PRENATAL SCREENING; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 33644621357     PISSN: 10597700     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10897-005-6390-7     Document Type: Article

References (17)

1. Benn, P. A., Fang, M., Egan, J. F. X., Horne, D., & Collins, R. (2003). Incorporation of Inhibin-A in second-trimester screening for Down syndrome. Obstet Gynecol, 10, 451-454.
2. Benn, P., Wright, D., & Cuckle, D. (2005). Practical strategies for contingent sequential screening for Down's syndrome. Prenat Diagn, 25, 645-652.
3. Bindra, A., Heath, V., Liao, A., Spencer, K., & Nicolaides, K. H. (2002). One-stop clinic for assessment for risk for trisomy 21 at 11-14 weeks: A prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol, 20, 219-225.
4. Bray, I., Wright, D. E., Davies, C., & Hook, E. B. (1998). Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn, 18, 9-20.
5. Chen, J., Heffley, D., Beazoglou, T., & Benn, P. A. (2000). Utilization of amniocentesis by women screen-positive for Down syndrome by the second trimester triple test. Community Genet, 3, 24-30.
6. Copel, J. A., & Bahado-Singh, R. O. (1990). Prenatal screening for Down's syndrome - a search for family's values. N Engl J Med, 341, 521-522.
7. Malone, F. (2005). Letter to the Editor: Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol, 105, 438.
8. National Center for Health Statistics. (2002). Vital statistics of the United States, 2000. Natality Data Set. Hyattsville, MD. CD ROM, Series 21:14, Hyattsville, MD.
9. Platt, L. D., Greene, N., Johnson, A., Zachary. J., Thom, E., Krantz, D., et al. (2004). Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol, 104, 661-666.
10. Wald, N. J., Cuckle, H. S., Densem, J. W., Nanchahal, K., Royston, P., Chard, T., et al (1988). Maternal serum screening for Down's syndrome in early pregnancy. BMJ, 297, 883-887.
11. Wald, N., Watt, H. C., & Hackshaw, A. K. (1999). Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med, 341, 461-467.
12. Wald, N. (2000). Down's syndrome. In N. Wald & I. Leck (Eds.), Antenatal and neonatal screening, 2nd ed. (pp. 83-115). Oxford. UK: Oxford University Press.
13. Wald, N. J., Huttley, W. J., & Hackshaw, A. K. (2003a). Antenatal screening for Down's syndrome with the quadruple test. Lancet, 361, 835-836.
14. Wald, N. J., Rodeck. C., Hackshaw, A. K., Walters, J., Chitty, L., & Mackinson, A. M. (2003b). First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen, 10, 56-104.
15. Wald, N., Rodeck, C., Rudnicka, A., & Hackshaw, A. (2004). Letter to the editor. Nuchal translucency and gestational age. Prenat Diagn, 24, 150-151.
16. Wapner, R., Thorn, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., et al. (2003). First trimester screening for trisomies 21 and 18. N Engl J Med, 349, 1405-1413.
17. Wright, D., Bradbury, I., Benn, P., Cuckle, H., & Ritchie, K. (2004). Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn, 24, 762-766.